• Most Popular
  • Most Shared

Crucell antibody beats Tamiflu in preclinical test

Thu Dec 11, 2008 2:50am EST

Stocks

   

LONDON, Dec 11 (Reuters) - An experimental antibody drug against influenza from Crucell (CRCL.AS) has strongly outperformed Roche's (ROG.VX) market-leading Tamiflu pill in preclinical tests, the Dutch biotech firm said on Thursday.

Crucell's mAb CR6261 was tested against a number of flu strains, including the bird flu strain H5N1, which experts fear has the potential to cause a pandemic in humans.

The results were presented at an antibody engineering conference in San Diego.

Because Crucell's product has yet to enter human tests, it is still many years away from reaching the market and may yet run into unexpected hurdles in clinical trials. (Reporting by Ben Hirschler, editing by Will Waterman)



More from Reuters

Joint Terminal Attack Controller SSgt Clinton J. Herbison, a U.S. Airman from the 817 Expeditionary Air Support Operations Squadron (EASOS) takes a break during a night mission near Honaker Miracle camp at the Pesh valley of Kunar Province August 12, 2009. Credit: REUTERS/Carlos Barria

Pictures of the Year

A look at the best photos of 2009.  Slideshow 

    The Dalai Lama jokes with a nasal spray after being asked his opinion on the swine flu during a press conference after his first lecture in Lausanne, Switzerland, August 4, 2009. REUTERS/ Valentin Flauraud

    What a wacky year it's been...

    Um, what's up the Dalai Lama's nose? "Oddly Enough" editor Bob Basler rounds up the goofiest photos of the year.  Full Article 

    A caution sign is seen next to a stock board at the Australian Securities Exchange (ASX) in Sydney September 5, 2008. REUTERS/Daniel Munoz
    Political Risk in 2010:

    Don't say we didn't warn you

    With the financial crisis (mostly) in the past, U.S. investors are eying a fresh start to the coming year. Here's a look at what speedbumps lie ahead.  Full Article